» Articles » PMID: 27356651

Anti-glutamic Acid Decarboxylase Antibody Positive Neurological Syndromes

Overview
Specialty Neurology
Date 2016 Jul 1
PMID 27356651
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

A rare kind of antibody, known as anti-glutamic acid decarboxylase (GAD) autoantibody, is found in some patients. The antibody works against the GAD enzyme, which is essential in the formation of gamma aminobutyric acid (GABA), an inhibitory neurotransmitter found in the brain. Patients found with this antibody present with motor and cognitive problems due to low levels or lack of GABA, because in the absence or low levels of GABA patients exhibit motor and cognitive symptoms. The anti-GAD antibody is found in some neurological syndromes, including stiff-person syndrome, paraneoplastic stiff-person syndrome, Miller Fisher syndrome (MFS), limbic encephalopathy, cerebellar ataxia, eye movement disorders, and epilepsy. Previously, excluding MFS, these conditions were calledhyperexcitability disorders. However, collectively, these syndromes should be known as "anti-GAD positive neurological syndromes." An important limitation of this study is that the literature is lacking on the subject, and why patients with the above mentioned neurological problems present with different symptoms has not been studied in detail. Therefore, it is recommended that more research is conducted on this subject to obtain a better and deeper understanding of these anti-GAD antibody induced neurological syndromes.

Citing Articles

Coexistence of Anti-GAD and Anti-GABAAR Antibodies in an Autoimmune Encephalitis Patient: A Case Report.

Lu X, Wu H, Tan Y, Mao X Int Med Case Rep J. 2025; 18():105-109.

PMID: 39840235 PMC: 11748031. DOI: 10.2147/IMCRJ.S488194.


SARS-CoV-2-Vaccine-Related Endocrine Disorders: An Updated Narrative Review.

Ishay A, Oleinikov K, Chertok Shacham E Vaccines (Basel). 2024; 12(7).

PMID: 39066388 PMC: 11281608. DOI: 10.3390/vaccines12070750.


A candidate projective neuron type of the cerebellar cortex: the synarmotic neuron.

Flace P, Galletta D, Bizzoca A, Gennarini G, Livrea P Eur J Histochem. 2024; 68(2).

PMID: 38766720 PMC: 11148694. DOI: 10.4081/ejh.2024.3954.


Three Patients With Chorea and Positive Voltage-Gated Potassium Channel Antibody: Is This the Link Between Hyperkinetic von Economo Disease and COVID-19?.

Dulanto J, Chu D, Saffari P, Abdelshahid M, Xu P, Hauser J Cureus. 2023; 15(3):e35666.

PMID: 36875252 PMC: 9981230. DOI: 10.7759/cureus.35666.


Associations between glutamic acid decarboxylase antibodies, oxidative stress markers, and cognitive capacity in adolescents who stutter.

Almudhi A, Gabr S Saudi J Biol Sci. 2023; 30(3):103580.

PMID: 36844638 PMC: 9943924. DOI: 10.1016/j.sjbs.2023.103580.


References
1.
Carra-Dalliere C, Thouvenot E, Bonafe A, Ducray F, Touchon J, Charif M . [Anti-GAD antibodies in paraneoplastic cerebellar ataxia associated with limbic encephalitis and autonomic dysfunction]. Rev Neurol (Paris). 2012; 168(4):363-6. DOI: 10.1016/j.neurol.2011.07.018. View

2.
McHugh J, Murray B, Renganathan R, Connolly S, Lynch T . GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma. Mov Disord. 2007; 22(9):1343-6. DOI: 10.1002/mds.21374. View

3.
Kimoto K, Koga M, Odaka M, Hirata K, Takahashi M, Li J . Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Neurology. 2006; 67(10):1837-43. DOI: 10.1212/01.wnl.0000244468.22377.6b. View

4.
Mori M, Kuwabara S, Fukutake T, Hattori T . Plasmapheresis and Miller Fisher syndrome: analysis of 50 consecutive cases. J Neurol Neurosurg Psychiatry. 2002; 72(5):680. PMC: 1737859. DOI: 10.1136/jnnp.72.5.680. View

5.
Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I . Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 1993; 43(10):1911-7. DOI: 10.1212/wnl.43.10.1911. View